|
View Agenda and
Faculty | Register | Exit
Who Should Participate
This
activity is intended for internal medicine physicians and other healthcare
professionals interested in the diagnosis and treatment of bipolar
disorder.
Overview
This educational activity will
address performance gaps in the diagnosis and treatment of bipolar
disorder. Bipolar disorder is often misdiagnosed and, thus,
inappropriately treated. It has problematic patient safety profiles with
high potential for severe comorbid conditions and suicide and contributes
to the growth in prison and homeless populations.
This
activity will present the latest clinically useful information based on
relevant treatment guidelines, evidence-based practice initiatives, and
recent results
of clinical trials such as Systematic Treatment Enhancement Program for
Bipolar Disorder (STEP-BD). Experts in bipolar disorder will present
participants
with practical and effective diagnostic and disease management strategies
that incorporate current understanding about necessary ethnic and
cultural considerations.
Learning
Objectives
Upon
completion of this activity, participants should be able to
|
|
1. |
Evaluate
all patients who present with depression for the presence of prior
or current symptoms and/or behaviors associated with mania or
hypomania, and refer for psychiatric treatment as necessary. |
|
2. |
Recognize
medical comorbidities and collaborate with the psychiatrist in
management of adverse events to improve patients’ treatment
compliance
and therapeutic outcomes. |
|
3. |
Develop a plan to
monitor the medical and psychosocial implications of the use of
pharmacologic therapies for the maintenance treatment of bipolar
disorder and
recommend
appropriate psychoeducation. |
|
4. |
Develop
strategies to overcome barriers to treatment posed by ethnic and
cultural factors present in African American or Hispanic patients
with
bipolar disorder. |
Accreditation
Statement
This
activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship of the
University
of
California
, Irvine School of Medicine (UCI) and CME Enterprise. The
University
of
California
, Irvine School of Medicine is accredited by the ACCME to provide
continuing medical education for physicians.
Credit Designation
Statement
The
University
of
California, Irvine School of Medicine designates this educational activity for a
maximum of 2.0 AMA PRA Category 1
Credits™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
General Disclosure Statement
It is the policy of the
University
of
California, Irvine School of Medicine and the University
of
California CME Consortium
to ensure balance, independence, objectivity and scientific rigor in all
CME activities. Full disclosure of conflict resolution will be made
in writing via handout materials or syllabus.
This activity is in compliance with California
Assembly Bill 1195, which requires continuing medical education
activities with patient care components to include curriculum in the
subjects of cultural and linguistic competency. For specific information
regarding Bill 1195 and definitions of cultural and linguistic
competency, please visit the CME Web site at www.cme.uci.edu.
| Supported by an educational grant from
Eli Lilly and Company
|
|
 |
|
 |
The
University
of California, Irvine School of Medicine and
CME Enterprise fully
comply with the legal requirements of the Americans with
Disabilities Act and the rules and regulations thereof. If any
participant who is planning to attend this educational activity has
an on-site need,
please call Bill Heckaman at 317.208.3615 by May 7,
2008, in order to receive service. |
[
Top ]
|
